- Home
- NOTE vs ABVC Comparison
NOTE vs ABVC Comparison
Compare NOTE & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- ABVC
- Stock Information
- Founded
- NOTE 2013
- ABVC 2015
- Country
- NOTE United States
- ABVC United States
- Employees
- NOTE N/A
- ABVC N/A
- Industry
- NOTE EDP Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- ABVC Health Care
- Exchange
- NOTE Nasdaq
- ABVC Nasdaq
- Market Cap
- NOTE 63.9M
- ABVC 52.1M
- IPO Year
- NOTE N/A
- ABVC N/A
- Fundamental
- Price
- NOTE $4.00
- ABVC $2.77
- Analyst Decision
- NOTE Strong Buy
- ABVC
- Analyst Count
- NOTE 4
- ABVC 0
- Target Price
- NOTE $29.25
- ABVC N/A
- AVG Volume (30 Days)
- NOTE 257.5K
- ABVC 85.9K
- Earning Date
- NOTE 11-12-2025
- ABVC 11-13-2025
- Dividend Yield
- NOTE N/A
- ABVC N/A
- EPS Growth
- NOTE N/A
- ABVC N/A
- EPS
- NOTE N/A
- ABVC N/A
- Revenue
- NOTE $109,683,000.00
- ABVC $391,242.00
- Revenue This Year
- NOTE N/A
- ABVC $735.18
- Revenue Next Year
- NOTE $4.61
- ABVC N/A
- P/E Ratio
- NOTE N/A
- ABVC N/A
- Revenue Growth
- NOTE N/A
- ABVC 186.84
- 52 Week Low
- NOTE $3.80
- ABVC $0.40
- 52 Week High
- NOTE $24.36
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- NOTE 41.52
- ABVC 41.70
- Support Level
- NOTE $4.15
- ABVC $2.86
- Resistance Level
- NOTE $4.54
- ABVC $3.05
- Average True Range (ATR)
- NOTE 0.30
- ABVC 0.15
- MACD
- NOTE -0.13
- ABVC -0.02
- Stochastic Oscillator
- NOTE 1.81
- ABVC 3.47
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.